Is Bayer a buy?
Bayer AG shares surged higher on Tuesday this week on news that the German company forecast its peak sale of pharmaceuticals to €12 billion. Bayer forecast that its thrombosis treatment asundexian could bring in more than €5 billion. Revenue from…